With presentations from Industry experts, including a keynote from Ken Getz, Professor of Tufts Center for the Study of Drug Development, RBQM Live is the virtual event of 2022 that you absolutely cannot afford to miss.
Experts
[FROM ACROSS THE]
Industry
9
[SESSIONS]
#RBQMLIVE
[SPEAKERS]
The Lineup
Ken Getz
[Executive Director and Professor, Tufts Center for the Study of Drug Development]
Demetris Zambas
[Global Clinical Operations Leader, Pfizer]
Steve Gilbert
[Senior Director Statistics, Pfizer ]
Olivia Feiro
[Director, Risk Management and Analytics, CSL Behring]
Amit Gulwadi
[Vice President- Head of Transformation, Alexion]
Cris McDavid
[Cris McDavid, Associate Director, Global Clinical Operations, RBQM, Parexel]
Blake Jensen
[Quality and Compliance Executive, Adagio]
Lynne Cesario
[Senior Director, Risk Based Monitoring Program Lead, Pfizer]
Kathy Taylor
[Senior Director/Head Risk Evaluation and Adaptive Integrated Monitoring, Merck]
Peter Stokman
[Business Lead Clinical Data Reporting & Visualization Environment - Bayer]
Linda Sullivan
[Senior Advisor, Metrics & Performance Management WCG]
Joseph Dustin
[Vice President of Product Strategy for eCOA at Medable ]
Jonathan Rowe
[Principal, Head of R&D Quality, Operations and Risk Management at ZS]
Marion Wolfs
[Integrated Data Analytics and Reporting (IDAR) Organization - Janssen ]
Nicole Stansbury
[ACRO RBQM Working Group Member ]
Mayank Anand
[Vice President and Global Head for GSK]
Craig H. Lipset
[Managing Partner, Clinical Innovation Partners]
Richard Young
[Vice President, Strategy, Vault CDMS, Veeva Systems]
Jessica Jackson
[Jessica Jackson, Head of Clinical Operations, Galderma ]